Respiratory chain dysfunction associated with multiple mitochondrial DNA deletions in antiretroviral therapy-related lipodystrophy.


Autoria(s): Miró, Òscar; Gómez, Montserrat; Pedrol, Enric; Cardellach, Francesc; Nunes Martínez, Virginia; Casademont i Pou, Jordi
Contribuinte(s)

Universitat de Barcelona

Data(s)

03/05/2013

Resumo

Highly-active antiretroviral therapy (HAART) can induce a characteristic lipodystrophy syndrome characterized by peripheral fat wasting and central adiposity, usually associated with hyperlipidaemia and insulin resistance [1,2]. Indirect data have led some authors to propose that mitochondrial dysfunction could play a role in this syndrome [3,4].To date, as recently outlined by Kakuda et al. [5] in this journal, HIV-infected patients developing lipodystrophy have not been studied for mitochondrial changes or respiratory chain capacity...

Identificador

http://hdl.handle.net/2445/41644

Idioma(s)

eng

Publicador

Lippincott Williams & Wilkins

Direitos

(c) Lippincott Williams & Wilkins, 2000

info:eu-repo/semantics/openAccess

Palavras-Chave #Antiretrovirals #Infeccions per VIH #Antiretroviral agents #HIV infections
Tipo

info:eu-repo/semantics/article

info:eu-repo/semantics/acceptedVersion